Semaglutide
-
healthAI Analysis of Reddit Posts Reveals Potential Hidden Side Effects of Ozempic
Researchers used AI to analyze Reddit posts, uncovering unreported side effects of GLP-1 drugs like Ozempic and Wegovy.
-
healthExercise Boosts Ozempic Benefits, Preserves Muscle in Obesity Study
New research at EAS 2026 shows combining semaglutide with exercise preserves muscle and enhances fat loss.
-
healthNovo Nordisk Cuts Ozempic Price in Canada to Compete with Generics
Novo Nordisk reduces Ozempic cost for uninsured Canadians as generic semaglutide enters the market, slashing prices by roughly a third.
-
healthStudy: GLP-1 Drugs Don't Disrupt Esophageal Function in Diabetes
New research shows GLP-1 receptor agonists do not significantly alter esophageal motility or reflux testing in type 2 diabetes patients.
-
healthGlobal Obesity Crisis Widens as Treatment Access Lags in Hardest-Hit Regions
New research reveals obesity rates are accelerating in developing nations while GLP-1 drugs remain concentrated in wealthier countries, highlighting a critical equity gap.
-
healthGeneric Semaglutide Hits Canadian Pharmacies This Week at Lower Cost
First generic semaglutide arrives in Canadian pharmacies at a fraction of the brand-name cost.
-
healthOrforglipron Pill Sustains Weight Loss After Injection Discontinuation
New trial shows oral GLP-1 orforglipron helps maintain weight loss after stopping injectable therapies tirzepatide and semaglutide.
-
healthNew Obesity Drug Outperforms Traditional Treatments in Early Trials
Experimental quintuple agonist shows promise in targeting obesity and diabetes by combining GLP-1, GIP, and PPAR activity.